肺がんリキッドバイオプシーの世界市場（～2026年）

• 英文タイトル：Global Lung Cancer Liquid Biopsy Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY12550
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は肺がんリキッドバイオプシーのグローバル市場について調査・分析したレポートです。種類別（CTC、CtDNA、エクソソーム・RNA、その他）市場規模、用途別（クリニック、病院、診療所研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別肺がんリキッドバイオプシーの競争状況、市場シェア
・世界の肺がんリキッドバイオプシー市場：種類別市場規模 2015年-2020年（CTC、CtDNA、エクソソーム・RNA、その他）
・世界の肺がんリキッドバイオプシー市場：種類別市場規模予測 2021年-2026年（CTC、CtDNA、エクソソーム・RNA、その他）
・世界の肺がんリキッドバイオプシー市場：用途別市場規模 2015年-2020年（クリニック、病院、診療所研究所）
・世界の肺がんリキッドバイオプシー市場：用途別市場規模予測 2021年-2026年（クリニック、病院、診療所研究所）
・北米の肺がんリキッドバイオプシー市場分析：米国、カナダ
・ヨーロッパの肺がんリキッドバイオプシー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの肺がんリキッドバイオプシー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の肺がんリキッドバイオプシー市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの肺がんリキッドバイオプシー市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Biocept、Exosome Diagnostics、F. Hoffmann-La Roche、Qiagen、Accuragen、Agena Bioscience、Bard1、Bgi
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer.
CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time.

Market Analysis and Insights: Global Lung Cancer Liquid Biopsy Market
The global Lung Cancer Liquid Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Lung Cancer Liquid Biopsy Scope and Market Size
Lung Cancer Liquid Biopsy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Liquid Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Biocept
Exosome Diagnostics
F. Hoffmann-La Roche
Qiagen
Accuragen
Agena Bioscience
Bard1
Bgi

Market segment by Type, the product can be split into
CTCs
CtDNA
Exosomes And RNA
Others
Market segment by Application, split into
Clinics
Hospitals
Physicians’ Office Laboratories

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lung Cancer Liquid Biopsy Revenue
1.4 Market by Type
1.4.1 Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CTCs
1.4.3 CtDNA
1.4.4 Exosomes And RNA
1.4.5 Others
1.5 Market by Application
1.5.1 Global Lung Cancer Liquid Biopsy Market Share by Application: 2020 VS 2026
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Physicians’ Office Laboratories
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Lung Cancer Liquid Biopsy Market Perspective (2015-2026)
2.2 Global Lung Cancer Liquid Biopsy Growth Trends by Regions
2.2.1 Lung Cancer Liquid Biopsy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lung Cancer Liquid Biopsy Historic Market Share by Regions (2015-2020)
2.2.3 Lung Cancer Liquid Biopsy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lung Cancer Liquid Biopsy Market Growth Strategy
2.3.6 Primary Interviews with Key Lung Cancer Liquid Biopsy Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Liquid Biopsy Players by Market Size
3.1.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue (2015-2020)
3.1.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Players (2015-2020)
3.1.3 Global Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lung Cancer Liquid Biopsy Market Concentration Ratio
3.2.1 Global Lung Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biopsy Revenue in 2019
3.3 Lung Cancer Liquid Biopsy Key Players Head office and Area Served
3.4 Key Players Lung Cancer Liquid Biopsy Product Solution and Service
3.5 Date of Enter into Lung Cancer Liquid Biopsy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Type (2015-2020)
4.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)
5.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Lung Cancer Liquid Biopsy Market Size (2015-2020)
6.2 Lung Cancer Liquid Biopsy Key Players in North America (2019-2020)
6.3 North America Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
6.4 North America Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)

7 Europe
7.1 Europe Lung Cancer Liquid Biopsy Market Size (2015-2020)
7.2 Lung Cancer Liquid Biopsy Key Players in Europe (2019-2020)
7.3 Europe Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
7.4 Europe Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)

8 China
8.1 China Lung Cancer Liquid Biopsy Market Size (2015-2020)
8.2 Lung Cancer Liquid Biopsy Key Players in China (2019-2020)
8.3 China Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
8.4 China Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)

9 Japan
9.1 Japan Lung Cancer Liquid Biopsy Market Size (2015-2020)
9.2 Lung Cancer Liquid Biopsy Key Players in Japan (2019-2020)
9.3 Japan Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
9.4 Japan Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Lung Cancer Liquid Biopsy Market Size (2015-2020)
10.2 Lung Cancer Liquid Biopsy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
10.4 Southeast Asia Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)

11 India
11.1 India Lung Cancer Liquid Biopsy Market Size (2015-2020)
11.2 Lung Cancer Liquid Biopsy Key Players in India (2019-2020)
11.3 India Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
11.4 India Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Lung Cancer Liquid Biopsy Market Size (2015-2020)
12.2 Lung Cancer Liquid Biopsy Key Players in Central & South America (2019-2020)
12.3 Central & South America Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
12.4 Central & South America Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Biocept
13.1.1 Biocept Company Details
13.1.2 Biocept Business Overview
13.1.3 Biocept Lung Cancer Liquid Biopsy Introduction
13.1.4 Biocept Revenue in Lung Cancer Liquid Biopsy Business (2015-2020))
13.1.5 Biocept Recent Development
13.2 Exosome Diagnostics
13.2.1 Exosome Diagnostics Company Details
13.2.2 Exosome Diagnostics Business Overview
13.2.3 Exosome Diagnostics Lung Cancer Liquid Biopsy Introduction
13.2.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
13.2.5 Exosome Diagnostics Recent Development
13.3 F. Hoffmann-La Roche
13.3.1 F. Hoffmann-La Roche Company Details
13.3.2 F. Hoffmann-La Roche Business Overview
13.3.3 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Introduction
13.3.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
13.3.5 F. Hoffmann-La Roche Recent Development
13.4 Qiagen
13.4.1 Qiagen Company Details
13.4.2 Qiagen Business Overview
13.4.3 Qiagen Lung Cancer Liquid Biopsy Introduction
13.4.4 Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
13.4.5 Qiagen Recent Development
13.5 Accuragen
13.5.1 Accuragen Company Details
13.5.2 Accuragen Business Overview
13.5.3 Accuragen Lung Cancer Liquid Biopsy Introduction
13.5.4 Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
13.5.5 Accuragen Recent Development
13.6 Agena Bioscience
13.6.1 Agena Bioscience Company Details
13.6.2 Agena Bioscience Business Overview
13.6.3 Agena Bioscience Lung Cancer Liquid Biopsy Introduction
13.6.4 Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
13.6.5 Agena Bioscience Recent Development
13.7 Bard1
13.7.1 Bard1 Company Details
13.7.2 Bard1 Business Overview
13.7.3 Bard1 Lung Cancer Liquid Biopsy Introduction
13.7.4 Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
13.7.5 Bard1 Recent Development
13.8 Bgi
13.8.1 Bgi Company Details
13.8.2 Bgi Business Overview
13.8.3 Bgi Lung Cancer Liquid Biopsy Introduction
13.8.4 Bgi Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
13.8.5 Bgi Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Lung Cancer Liquid Biopsy Key Market Segments
Table 2. Key Players Covered: Ranking by Lung Cancer Liquid Biopsy Revenue
Table 3. Ranking of Global Top Lung Cancer Liquid Biopsy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CTCs
Table 6. Key Players of CtDNA
Table 7. Key Players of Exosomes And RNA
Table 8. Key Players of Others
Table 9. Global Lung Cancer Liquid Biopsy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Lung Cancer Liquid Biopsy Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Lung Cancer Liquid Biopsy Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Lung Cancer Liquid Biopsy Market Share by Regions (2015-2020)
Table 13. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Lung Cancer Liquid Biopsy Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Lung Cancer Liquid Biopsy Market Growth Strategy
Table 19. Main Points Interviewed from Key Lung Cancer Liquid Biopsy Players
Table 20. Global Lung Cancer Liquid Biopsy Revenue by Players (2015-2020) (Million US$)
Table 21. Global Lung Cancer Liquid Biopsy Market Share by Players (2015-2020)
Table 22. Global Top Lung Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biopsy as of 2019)
Table 23. Global Lung Cancer Liquid Biopsy by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Lung Cancer Liquid Biopsy Product Solution and Service
Table 26. Date of Enter into Lung Cancer Liquid Biopsy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Lung Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 29. Global Lung Cancer Liquid Biopsy Market Size Share by Type (2015-2020)
Table 30. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2021-2026)
Table 31. Global Lung Cancer Liquid Biopsy Market Size Share by Application (2015-2020)
Table 32. Global Lung Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 33. Global Lung Cancer Liquid Biopsy Market Size Share by Application (2021-2026)
Table 34. North America Key Players Lung Cancer Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Lung Cancer Liquid Biopsy Market Share (2019-2020)
Table 36. North America Lung Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 37. North America Lung Cancer Liquid Biopsy Market Share by Type (2015-2020)
Table 38. North America Lung Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 39. North America Lung Cancer Liquid Biopsy Market Share by Application (2015-2020)
Table 40. Europe Key Players Lung Cancer Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Lung Cancer Liquid Biopsy Market Share (2019-2020)
Table 42. Europe Lung Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Lung Cancer Liquid Biopsy Market Share by Type (2015-2020)
Table 44. Europe Lung Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Lung Cancer Liquid Biopsy Market Share by Application (2015-2020)
Table 46. China Key Players Lung Cancer Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 47. China Key Players Lung Cancer Liquid Biopsy Market Share (2019-2020)
Table 48. China Lung Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 49. China Lung Cancer Liquid Biopsy Market Share by Type (2015-2020)
Table 50. China Lung Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 51. China Lung Cancer Liquid Biopsy Market Share by Application (2015-2020)
Table 52. Japan Key Players Lung Cancer Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Lung Cancer Liquid Biopsy Market Share (2019-2020)
Table 54. Japan Lung Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Lung Cancer Liquid Biopsy Market Share by Type (2015-2020)
Table 56. Japan Lung Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Lung Cancer Liquid Biopsy Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Lung Cancer Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Lung Cancer Liquid Biopsy Market Share (2019-2020)
Table 60. Southeast Asia Lung Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Lung Cancer Liquid Biopsy Market Share by Type (2015-2020)
Table 62. Southeast Asia Lung Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Lung Cancer Liquid Biopsy Market Share by Application (2015-2020)
Table 64. India Key Players Lung Cancer Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 65. India Key Players Lung Cancer Liquid Biopsy Market Share (2019-2020)
Table 66. India Lung Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 67. India Lung Cancer Liquid Biopsy Market Share by Type (2015-2020)
Table 68. India Lung Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 69. India Lung Cancer Liquid Biopsy Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Lung Cancer Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Lung Cancer Liquid Biopsy Market Share (2019-2020)
Table 72. Central & South America Lung Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Lung Cancer Liquid Biopsy Market Share by Type (2015-2020)
Table 74. Central & South America Lung Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Lung Cancer Liquid Biopsy Market Share by Application (2015-2020)
Table 76. Biocept Company Details
Table 77. Biocept Business Overview
Table 78. Biocept Product
Table 79. Biocept Revenue in Lung Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 80. Biocept Recent Development
Table 81. Exosome Diagnostics Company Details
Table 82. Exosome Diagnostics Business Overview
Table 83. Exosome Diagnostics Product
Table 84. Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 85. Exosome Diagnostics Recent Development
Table 86. F. Hoffmann-La Roche Company Details
Table 87. F. Hoffmann-La Roche Business Overview
Table 88. F. Hoffmann-La Roche Product
Table 89. F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 90. F. Hoffmann-La Roche Recent Development
Table 91. Qiagen Company Details
Table 92. Qiagen Business Overview
Table 93. Qiagen Product
Table 94. Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 95. Qiagen Recent Development
Table 96. Accuragen Company Details
Table 97. Accuragen Business Overview
Table 98. Accuragen Product
Table 99. Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 100. Accuragen Recent Development
Table 101. Agena Bioscience Company Details
Table 102. Agena Bioscience Business Overview
Table 103. Agena Bioscience Product
Table 104. Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 105. Agena Bioscience Recent Development
Table 106. Bard1 Company Details
Table 107. Bard1 Business Overview
Table 108. Bard1 Product
Table 109. Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 110. Bard1 Recent Development
Table 111. Bgi Business Overview
Table 112. Bgi Product
Table 113. Bgi Company Details
Table 114. Bgi Revenue in Lung Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 115. Bgi Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Liquid Biopsy Market Share by Type: 2020 VS 2026
Figure 2. CTCs Features
Figure 3. CtDNA Features
Figure 4. Exosomes And RNA Features
Figure 5. Others Features
Figure 6. Global Lung Cancer Liquid Biopsy Market Share by Application: 2020 VS 2026
Figure 7. Clinics Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Physicians' Office Laboratories Case Studies
Figure 10. Lung Cancer Liquid Biopsy Report Years Considered
Figure 11. Global Lung Cancer Liquid Biopsy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Lung Cancer Liquid Biopsy Market Share by Regions: 2020 VS 2026
Figure 13. Global Lung Cancer Liquid Biopsy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Lung Cancer Liquid Biopsy Market Share by Players in 2019
Figure 16. Global Top Lung Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biopsy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biopsy Revenue in 2019
Figure 18. North America Lung Cancer Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Lung Cancer Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Lung Cancer Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Lung Cancer Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Lung Cancer Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Lung Cancer Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Lung Cancer Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

乳癌リキッドバイオプシーの世界市場（～2026年）

Global Breast Cancer Liquid Biopsy Market Size, Status and Forecast 2020-2026
MRC2-11QY11191 2020年11月25日 99Pages
当調査資料は乳癌リキッドバイオプシーのグローバル市場について調査・分析したレポートです。種類別（循環腫瘍細胞（CTC）、無細胞DNA（CfDNA）、細胞外小胞（EV）、その他循環バイオマーカー）市場規模、用途別（病院、診断センター、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フ...

リキッドバイオプシー用循環バイオマーカーの世界市場（～2026年）

Global Circulating Biomarker for Liquid Biopsy Market Size, Status and Forecast 2020-2026
MRC2-11QY11377 2020年11月25日 91Pages
当調査資料はリキッドバイオプシー用循環バイオマーカーのグローバル市場について調査・分析したレポートです。種類別（循環腫瘍細胞（CTC）、循環腫瘍DNA（ctDNA）、無細胞DNA（cfDNA）、細胞外小胞（EV）、その他）市場規模、用途別（早期がん検診、治療法選択、治療モニタリング、再発モニタリング...

肺癌の世界市場（～2026年）

Global Lung Cancer Market Size, Status and Forecast 2020-2026
MRC2-11QY12551 2020年11月25日 92Pages
当調査資料は肺癌のグローバル市場について調査・分析したレポートです。種類別（手術、化学療法、放射線療法、光線力学療法、レーザー療法）市場規模、用途別（病院・クリニック、がん研究センター、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...

肺がん治療薬の世界市場（～2026年）

Global Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY12552 2020年11月25日 96Pages
当調査資料は肺がん治療薬のグローバル市場について調査・分析したレポートです。種類別（化学療法、標的療法、薬物、手術、放射線療法）市場規模、用途別（早期・中期肺がん治療、進行性肺がん治療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

小細胞肺がん治療の世界市場（～2026年）

Global Small Cell Lung Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04652 2020年11月20日 99Pages
当調査資料は小細胞肺がん治療のグローバル市場について調査・分析したレポートです。種類別（小細胞がん、混合型小細胞がん）市場規模、用途別（手術、放射線療法、化学療法）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オース...

非小細胞肺がん治療薬の世界市場（～2026年）

Global Non-small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04010 2020年11月20日 97Pages
当調査資料は非小細胞肺がん治療薬のグローバル市場について調査・分析したレポートです。種類別（Alimta、Iressa、Avastin、Tarceva、Zykadia、Tagrisso、Xalkori、Cyramza、Opdivo、Alecensa）市場規模、用途別（病院、クリニック）市場規模、地域...

肺がん診断の世界市場（～2026年）

Global Lung Cancer Diagnostics Market Size, Status and Forecast 2020-2026
MRC2-11QY12549 2020年11月25日 90Pages
当調査資料は肺がん診断のグローバル市場について調査・分析したレポートです。種類別（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他）市場規模、用途別（産業、医療、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、...

肺がん診断・治療の世界市場（～2026年）

Global Lung Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY12547 2020年11月25日 128Pages
当調査資料は肺がん診断・治療のグローバル市場について調査・分析したレポートです。種類別（非小細胞肺がん、小細胞肺がん）市場規模、用途別（病院、がん研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

小細胞肺がん治療薬の世界市場（～2026年）

Global Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04651 2020年11月20日 133Pages
当調査資料は小細胞肺がん治療薬のグローバル市場について調査・分析したレポートです。種類別（生物製剤、小分子）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、...

肺がん診断検査の世界市場（～2026年）

Global Lung Cancer Diagnostic Tests Market Size, Status and Forecast 2020-2026
MRC2-11QY12548 2020年11月25日 94Pages
当調査資料は肺がん診断検査のグローバル市場について調査・分析したレポートです。種類別（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他診断方法）市場規模、用途別（精密医療、個別化医療、がんモニタリング）市場規模、地域別（北米、米...

乳癌リキッドバイオプシーの世界市場（～2026年） Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers. Market Analysis and Insights: Global Breast Cancer …
リキッドバイオプシー用循環バイオマーカーの世界市場（～2026年） Market Analysis and Insights: Global Circulating Biomarker for Liquid Biopsy Market The global Circulating Biomarker for Liquid Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Circulating Biomarker for Liquid Bi…
肺癌の世界市場（～2026年） Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as prim…
肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Therapeutics Market The global Lung Cancer Therapeutics market size is projected to reach US$ 15800 million by 2026, from US$ 14180 million in 2020, at a CAGR of 10.6%% during 2021-2026. Global Lung Cancer Therapeutics Scope and Market Size Lung Cance…
小細胞肺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Small Cell Lung Cancer Treatment Scope and Market…